Measuring blood levels of vaspin could independently predict major adverse cardiac events (MACE) in patients who have suffered acute myocardial infarction (AMI), according to research published Jan. 16 in the Journal of the American Heart Association, potentially improving early risk stratification in heart attack survivors.

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Rising drug prices have caught the attention of the Congressional Committee on Oversight and Reform, which announced it will open a “sweeping” drug price investigation.

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

Scientists at the University of Surrey in Guildford, England, developed a tool that uses machine learning to identify and treat urinary tract infections at early stages in dementia patients, according to a study published in PLOS One.

A coordinated program to reduce fluoroscopy radiation resulted in a three- to eight-fold reduction in high-dose procedures performed over an eight-year period, according to a single-center study published Jan. 15 in Radiology.

Artificial intelligence (AI) can be trained to predict a patient’s likelihood of axillary lymph node metastasis using a breast MRI dataset, according to a study published in the Journal of Digital Imaging.

Following simple heart health guidelines may also cut individuals’ 10-year risk of developing diabetes, Ohio State researchers reported Jan. 16.

Researchers at Duke University have been awarded a $196,000 grant to address a growing issue related to the use of artificial intelligence (AI) in healthcare: the gray area between explaining decisions to patients and protecting trade secrets associated with clinical decision support (CDS) software. 

“Knowing about the oxygenation (of tissues) might allow us to tailor the therapy to make it better and to use other therapeutic interventions that are more appropriate,” said Vikram Kodibagkar, PhD, an associate professor of engineering at Arizona State University in Tempe, according to a recent university news release.